US Patent 11183286 Neoantigen identification, manufacture, and use
Patent 11183286 was granted and assigned to Gritstone Bio on November, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+444 characters)
Article
Patent abstract
Disclosed herein is a system and methods for determining the alleles, neoantigens, and vaccine composition as determined on the basis of an individual's tumor mutations. Also disclosed are systems and methods for obtaining high quality sequencing data from a tumor. Further, described herein are systems and methods for identifying somatic changes in polymorphic genome data. Finally, described herein are unique cancer vaccines.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Adnan Derti0
Brendan Bulik-Sullivan0
Jennifer Busby0
Roman Yelensky0
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111832860
Date of Patent
November 23, 2021
0Patent Application Number
171015180
Date Filed
November 23, 2020
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 25 Nov, 2021
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 11183286 Neoantigen identification, manufacture, and use
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11183286
Date of patent
November 23, 2021
Patent application number
17101518
Date Filed
November 23, 2020
Patent primary examiner
Find more entities like US Patent 11183286 Neoantigen identification, manufacture, and use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
